BOWMAN: Electrical Stimulation of Abdominal Muscles for Bowel Management in People With Spinal Cord Injury

Sponsor
Salisbury NHS Foundation Trust (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04307303
Collaborator
Inspire Foundation (Other)
36
2
36

Study Details

Study Description

Brief Summary

A well-managed bowel program is an essential part of daily life for many people with a SCI. Nevertheless, constipation is frequently reported (42-95%). Constipation embraces a spectrum of harms including both physical & psychological distress. Initial exploratory studies suggest abdominal FES may be useful for decreasing overall bowel management time, decreasing colonic transit time and reducing discomfort. The current study will seek to reproduce previous findings in a 12 week study, using overall bowel managementitme as a benchmark for establishing proof of principle. The study will include 36 people with a spinal cord injury aged 18 and over with an above T12 injury, a complete or incomplete lesion in a medically stable condition, one year or more after injury. Participants will be randomised into two groups. One group will receive abdominal electrical stimulation and the other group low dose abdominal electrical stimulation. Participants will be asked to keep a bowel diary and complete questionnaires examining quality of life and bowel management.

Condition or Disease Intervention/Treatment Phase
  • Device: abdominal functional electrical stimulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Randomised Sham-controlled, Proof of Principle Study of Abdominal Functional Electrical Stimulation (ABFES) for Bowel Management in Spinal Cord Injury (SCI)
Anticipated Study Start Date :
May 1, 2020
Anticipated Primary Completion Date :
May 1, 2022
Anticipated Study Completion Date :
May 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Abdominal functional electrical stimulation

Device: abdominal functional electrical stimulation
functional electrical stimulation of the abdominal muscles
Other Names:
  • ABFES
  • Sham Comparator: Low dose abdominal functional electrical stimulation arm

    Device: abdominal functional electrical stimulation
    functional electrical stimulation of the abdominal muscles
    Other Names:
  • ABFES
  • Outcome Measures

    Primary Outcome Measures

    1. Time required for defecation [8 weeks]

    Secondary Outcome Measures

    1. Neurogenic bowel dysfunction score [8 weeks]

    2. Male/Female sexual function index [8 weeks]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    People with a diagnosis of SCI (age=>18) above T12 complete or incomplete lesion in a medically stable condition with a reflex bowel =>1 year post spinal injury).

    -

    Exclusion Criteria:

    A history of organic bowel obstruction, frequent opioid use, intrathecal baclofen or percutaneous endoscopic gastrostomy, inflammatory bowel disease, abdominal hernia, any gastrointestinal or abdominal surgery (not necessarily excluded unless recent will require further investigation), lower motor neuron lesions, suspected strictures or fistulae along the gastrointestinal tract, physiologic gastrointestinal obstruction. Other causes of constipation such as hypothyroidism, hypercalcaemia and a prior history of constipation predominant IBS prior to diagnosis of SCI. Involvement in other research trial interventions likely to have an impact on the protocol or results of the current study.

    Contra indications to electrical stimulation Poorly controlled epilepsy, cardiac pacemaker in situ or other implanted electrical devices (will require further investigation to examine whether there is an interaction between the device and FES) pregnancy or pregnancy planned, cancerous tissue in the abdominal region, any major skin disorders affecting the abdominal area) severe autonomic dysreflexia (tested at initial assessment).

    -

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Salisbury NHS Foundation Trust
    • Inspire Foundation

    Investigators

    • Principal Investigator: Tamsyn Street, Salisbury NHS Foundation Trust

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Salisbury NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT04307303
    Other Study ID Numbers:
    • BOWMAN
    First Posted:
    Mar 13, 2020
    Last Update Posted:
    Mar 13, 2020
    Last Verified:
    Mar 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 13, 2020